These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12816658)

  • 21. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer selection.
    Leroi AM; Koufopanou V; Burt A
    Nat Rev Cancer; 2003 Mar; 3(3):226-31. PubMed ID: 12612657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 4-mutation model of carcinogenesis for tumour suppressor genes.
    Den Otter W; Koten JW
    Anticancer Res; 1999; 19(6A):4845-52. PubMed ID: 10697598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
    Nichols KE; Malkin D; Garber JE; Fraumeni JF; Li FP
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):83-7. PubMed ID: 11219776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determining cancer risk: the evolutionary multistage model or total stem cell divisions?
    Nunney L; Thai K
    Proc Biol Sci; 2020 Dec; 287(1941):20202291. PubMed ID: 33323077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic factors involved in cancer susceptibility].
    Kohno T; Yokota J
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1255-62. PubMed ID: 12146010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanism of carcinogenesis in familial tumors.
    Tamura K; Utsunomiya J; Iwama T; Furuyama J; Takagawa T; Takeda N; Fukuda Y; Matsumoto T; Nishigami T; Kusuhara K; Sagayama K; Nakagawa K; Yamamura T
    Int J Clin Oncol; 2004 Aug; 9(4):232-45. PubMed ID: 15375699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolutionary dynamics of tumor suppressor gene inactivation.
    Nowak MA; Michor F; Komarova NL; Iwasa Y
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10635-8. PubMed ID: 15252197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Information dynamics in carcinogenesis and tumor growth.
    Gatenby RA; Frieden BR
    Mutat Res; 2004 Dec; 568(2):259-73. PubMed ID: 15542113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cancer genetics: estimation of the needs of the population in France for the next ten years].
    Bonaïti-Pellié C; Andrieu N; Arveux P; Bonadona V; Buecher B; Delpech M; Jolly D; Julian-Reynier C; Luporsi E; Noguès C; Nowak F; Olschwang S; Orsi F; Pujol P; Saurin JC; Sinilnikova O; Stoppa-Lyonnet D; Thépot F
    Bull Cancer; 2009 Sep; 96(9):875-900. PubMed ID: 19751997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic mutations in organisms with complex life histories.
    Orive ME
    Theor Popul Biol; 2001 May; 59(3):235-49. PubMed ID: 11444962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Heredity in renal and prostatic neoplasia].
    Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
    Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative clonal selection in tumor evolution.
    Beckman RA; Loeb LA
    Genetics; 2005 Dec; 171(4):2123-31. PubMed ID: 16143627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rare genetic variants and the risk of cancer.
    Bodmer W; Tomlinson I
    Curr Opin Genet Dev; 2010 Jun; 20(3):262-7. PubMed ID: 20554195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nakahara memorial lecture. Hereditary cancer, oncogenes, and anti-oncogenes.
    Knudson AG
    Princess Takamatsu Symp; 1989; 20():15-29. PubMed ID: 2577335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Context-dependent selection as the keystone in the somatic evolution of cancer.
    Vibishan B; Watve MG
    Sci Rep; 2020 Mar; 10(1):4223. PubMed ID: 32144283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium.
    Lancet; 1997 May; 349(9064):1505-10. PubMed ID: 9167459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passenger mutations can accelerate tumour suppressor gene inactivation in cancer evolution.
    Wodarz D; Newell AC; Komarova NL
    J R Soc Interface; 2018 Jun; 15(143):. PubMed ID: 29875280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.